Biophytis SA
DelistedCIK 1768946fmd_1KA5XEYXJKZKY52HVN0M32R6SWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2023, 6 periods
Latest annual · FY2023
Millions- Operating income
- (14)
- Net income
- (17)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
Biophytis SA financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -€14.3 million | -€23.3 million | 20-F 2024-04-08 · proof | |
| Net income | -€17 million | -€24.2 million | 20-F 2024-04-08 · proof | |
| Cash from operating activities | -€12.9 million | -€19 million | 20-F 2024-04-08 · proof | |
| Total assets | €12 million | €22 million | -45.6% | 20-F 2024-04-08 · proof |
| Total liabilities | €15.8 million | €23.9 million | -33.7% | 20-F 2024-04-08 · proof |
| Cash and cash equivalents | €5.6 million | €11.1 million | -49.6% | 20-F 2024-04-08 · proof |
| Total debt | €8.3 million | €14.6 million | -43.3% | 20-F 2024-04-08 · proof |
- What was Biophytis SA's operating income in fiscal 2023?
- Biophytis SA reported operating income of -€14.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -€23.3 million the year before. Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What was Biophytis SA's net income in fiscal 2023?
- Biophytis SA reported net income of -€17 million for fiscal 2023 (the year ended Dec 31, 2023), against -€24.2 million the year before. Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What was Biophytis SA's cash from operating activities in fiscal 2023?
- Biophytis SA reported cash from operating activities of -€12.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -€19 million the year before. Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What are Biophytis SA's total assets?
- As of Dec 31, 2023, Biophytis SA reported total assets of €12 million, against €22 million a year earlier (-45.6%). Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What are Biophytis SA's total liabilities?
- As of Dec 31, 2023, Biophytis SA reported total liabilities of €15.8 million, against €23.9 million a year earlier (-33.7%). Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What are Biophytis SA's cash and cash equivalents?
- As of Dec 31, 2023, Biophytis SA reported cash and cash equivalents of €5.6 million, against €11.1 million a year earlier (-49.6%). Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
- What is Biophytis SA's total debt?
- As of Dec 31, 2023, Biophytis SA reported total debt of €8.3 million, against €14.6 million a year earlier (-43.3%). Source: the 20-F filed with the SEC on Apr 8, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1768946&period_type=annual&limit=5"Information only, not investment advice.